Next Article in Journal
Assessment of Thermal Transitions by Dynamic Mechanical Analysis (DMA) Using a Novel Disposable Powder Holder
Next Article in Special Issue
Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies
Previous Article in Journal / Special Issue
Ingredient Consistency of Commercially Available Polyphenol and Tocopherol Nutraceuticals
Article Menu

Export Article

Open AccessArticle
Pharmaceutics 2010, 2(1), 61-77; doi:10.3390/pharmaceutics2010061

The Effects of Pregnenolone 16α-Carbonitrile Dosing on Digoxin Pharmacokinetics and Intestinal Absorption in the Rat

1
Epithelial Research Group, Institute for Cell and Molecular Biosciences, Medical School, Newcastle University, NE2 4HH, UK
2
Discovery Drug Metabolism and Pharmacokinetics, AstraZeneca Research & Development, 431 83 Mölndal, Sweden
Current address: Drug Metabolism and Pharmacokinetics, AstraZeneca Research & Development, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK.
*
Author to whom correspondence should be addressed.
Received: 1 February 2010 / Revised: 5 March 2010 / Accepted: 11 March 2010 / Published: 15 March 2010
(This article belongs to the Special Issue What's on Board in Pharmaceutics)
View Full-Text   |   Download PDF [329 KB, uploaded 15 March 2010]   |  

Abstract

The effect of Pgp induction in rats by pregnenolone 16α-carbonitrile (PCN) (3 days, 35 mg/kg/d, p.o.) on digoxin pharmacokinetics and intestinal transport has been assessed. After intravenous or oral digoxin dosing the arterial and hepatic portal vein (oral) AUC(0-24h) were significantly reduced by PCN pre-treatment. Biliary digoxin clearance increased 2-fold following PCN treatment. PCN significantly increased net digoxin secretion (2.05- and 4.5-fold respectively) in ileum and colon but not in duodenum or jejunum. This increased secretion correlated with increased Pgp protein expression in ileum and colon. Both intestinal and biliary excretion therefore contribute to altered digoxin disposition following PCN.
Keywords: ATP-binding cassette; ABCB1; P-glycoprotein; pregnane X receptor; pregnenolone 16α-carbonitrile; induction; digoxin; pharmacokinetics; disposition; intestinal transport ATP-binding cassette; ABCB1; P-glycoprotein; pregnane X receptor; pregnenolone 16α-carbonitrile; induction; digoxin; pharmacokinetics; disposition; intestinal transport
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lowes, S.; Haslam, I.S.; Fihn, B.-M.; Hilgendorf, C.; Karlsson, J.E.; Simmons, N.L.; Ungell, A.-L. The Effects of Pregnenolone 16α-Carbonitrile Dosing on Digoxin Pharmacokinetics and Intestinal Absorption in the Rat. Pharmaceutics 2010, 2, 61-77.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top